Free CEUs & CME for Pharmacists
The CME & Contact Hours You Need Today for RPh License Renewal
We are proud to sponsor this educational initiative, dedicated to providing free Pharmacist CME, CEUs & CPE required by many state boards for Pharmacist license renewal. Check back often for updates, including new free Pharmacist CME courses offering free CEUs that are posted frequently. Through extensive content review, our staff approves free Pharmacist CEU courses that are timely and approved for ACPE Credit.**
|
To check Pharmacist CPE requirements by STATE CLICK HERE!
|
1.0 Free CEUs Naloxone: The Universal Antidote for Opioid Overdose- Identify patients at increased risk for opioid overdose and diagnose patients presenting with drug overdoses, including those patients with respiratory and central nervous system depression. Evaluate recently developed treatments for opioid overdoses and their potential use by at-risk individuals and their families, Educate patients and caretakers about how to administer naloxone, how to re-evaluate the patient as the naloxone wears off, and how to inform emergency personnel of known or suspected opioid overdose.
|
& be notified new FREE CME has posted!
Featured Free CME of the Month
NEW! 1.25 Free Contact Hours A Balancing Act: Immunosuppression in Transplant Medicine- Describe the causes of antibody-mediated complications in kidney and liver transplants. Implement regular monitoring strategies that can optimize appropriate immunosuppression while managing side effects in transplant patients.Engage transplant patients to become participants in their treatment to promote adherence to medications and improve outcomes. (+MD)
1.0 Free Contact Hours Inhaled Insulin – A Breath of Fresh Air for the Treatment of Diabetes–Compare the PK/PD profile of inhaled insulin to those of currently available injectable rapid-acting prandial insulins. Review the safety and efficacy data for recently approved inhaled insulin in patients with diabetes. Recognize clinical scenarios in which inhaled insulin would be an appropriate option for managing postprandial glucose excursions in patients with type 1 and type 2 diabetes. Discuss the circumstances when inhaled insulin is contraindicated and the role of pulmonary function testing in patients using inhaled insulin.
1.5 Free Contact Hours Year in Review: Advances in the Treatment of Multiple Sclerosis- Assess the impact of unmet treatment needs for patients with MSSummarize key recent evidence on the efficacy and safety of emerging therapies for relapsing and progressive forms of MS. Describe the general mechanisms of action for MS therapies that deplete B-cells, sequester T-cells, and promote neuroprotection. Apply evidence from recent clinical trials to guide effective treatment decisions for patients with MS. (+MD,PA,RN,NP)
1.5 Free Contact Hours Year in Review: Advances in the Treatment of Multiple Sclerosis- Assess the impact of unmet treatment needs for patients with MSSummarize key recent evidence on the efficacy and safety of emerging therapies for relapsing and progressive forms of MS. Describe the general mechanisms of action for MS therapies that deplete B-cells, sequester T-cells, and promote neuroprotection. Apply evidence from recent clinical trials to guide effective treatment decisions for patients with MS. (+MD,PA,RN,NP)
1.0 Free Contact Hours Defining the Role of Pharmacists in Advanced Gout Management- Discuss the pathophysiology of gout, its risk factors, and long-term complications. Outline the clinical profiles of available and emerging gout pharmacotherapies including safety, efficacy, mechanisms-of-action, implications, and potential shortfalls of conventional agents. Assist providers on the guideline-directed and individualized selection, modification, and monitoring of gout therapies. Counsel patients on non-pharmacologic and pharmacologic approaches to care, emphasizing the importance of adherence to therapies and lifestyle modifications.
|
|
1.0 Free Contact Hours Emergency Contraception: Clinical Aspects and Patient Care– List the currently available emergency contraception (EC) products and their OTC status. Describe the mechanism of action and adverse effects of EC products. Describe how patients obtain EC products, including age restrictions and specific state restrictions. Outline counseling points for patients taking EC products – instructions for use, side effects, and implications. Explain the specific FDA requirements and practice guidelines that govern the sale of EC products.
1.5 Free Contact Hours Advances in the Treatment of HIV Infection– Describe key updates to national HIV guidelines for initial treatment, use of co-formulations, monitoring treatment responses, and switching antiretroviral therapies. Differentiate the effectiveness of treatment options in HIV and their role in optimizing efficacy, safety, and adherence in HIV-infected patients. (+ MD,PA,NP,RN,CM,MA)
1.5 Free Contact Hours Advances in the Treatment of HIV Infection– Describe key updates to national HIV guidelines for initial treatment, use of co-formulations, monitoring treatment responses, and switching antiretroviral therapies. Differentiate the effectiveness of treatment options in HIV and their role in optimizing efficacy, safety, and adherence in HIV-infected patients. (+ MD,PA,NP,RN,CM,MA)
|
1.0 Free Contact Hours Ambulatory Care Pharmacy Practice: Demonstrating Success
This activity provides an overview of how ambulatory care pharmacists demonstrate success in different environments and how success is viewed by various stakeholders. Two successful practice models are discussed in their development and sustainability. Describe sustainable practice models that demonstrate value to stakeholders. Identify specific outcomes in ambulatory pharmacy practice that contribute to improved care delivery. Discuss opportunities for advancing ambulatory pharmacy practice across different practice settings. |
1.0 Free Contact Hours Direct-acting Oral Anticoapgulants and Guideline Updates: Preventing Stroke in Older Adults With Atrial Fibrillation- Determine when a patient with atrial fibrillation is at risk for stroke using evidence-based risk scoring assessments.Discuss the risk of stroke versus the risk of intracranial bleeding from anticoagulant therapy in patients with AF. Compare the benefits and risks of warfarin and direct-acting oral anticoagulant anticoagulant medications. Discuss reversal agents for non-warfarin anticoagulant medications that are currently under late-stage investigation. Describe a patient who should remain on warfarin therapy and a patient who should be considered for direct-acting oral anticoagulant therapy. Outline current evidence for prescribing aspirin for the prevention of stroke in patients with AF.
1.0 Free Contact Hours Utilizing Patient-Centered Approaches in Pulmonary Arterial Hypertension (PAH): The Expanding Role of Pharmacists- Explain how treatment algorithms and prognostic factors can be used to individualize care for patients with PAH when selecting initial treatmentEvaluate the role of the various therapeutic classes in the treatment of PAH, including balancing the benefits and risks of monotherapy versus combination therapy. Discuss the role of pharmacists as part of the interprofessional healthcare team when managing patients with PAH.
1.0 Free Contact Hours Safe Use of Concentrated Insulin: Helping Patients and Providers to Get It Right (Part 1)- Summarize the history and frequency of medication errors that occur with insulin use, including highly concentrated insulin U-500Explain how to calculate doses of U-500 insulin in “syringe units” for administration using a U-100 syringe and clearly instruct patients to convert insulin concentrations. Discuss the pharmacokinetic, pharmacodynamic, and clinical properties of concentrated insulin, including U-500 and others in development, and factors for safe administration. Describe the role of pharmacists in counseling patients who are transitioning from inpatient to outpatient settings, to minimize the risk of insulin-administration errors and hospital readmissions.
1.0 Free Contact Hours Safe Use of Concentrated Insulin: Helping Patients and Providers to Get It Right (Part 2)- Calculate doses of U-500 insulin in “syringe units” for administration using a U-100 syringe, and discuss methods for instructing patients to convert insulin concentrations. Incorporate clinical properties of concentrated insulins when developing patient care plans to ensure safe administration. Discuss strategies for counseling patients who are transitioning from inpatient to outpatient settings to minimize the risk of insulin-administration errors.
1.0 Free Contact Hours Utilizing Patient-Centered Approaches in Pulmonary Arterial Hypertension (PAH): The Expanding Role of Pharmacists- Explain how treatment algorithms and prognostic factors can be used to individualize care for patients with PAH when selecting initial treatmentEvaluate the role of the various therapeutic classes in the treatment of PAH, including balancing the benefits and risks of monotherapy versus combination therapy. Discuss the role of pharmacists as part of the interprofessional healthcare team when managing patients with PAH.
1.0 Free Contact Hours Safe Use of Concentrated Insulin: Helping Patients and Providers to Get It Right (Part 1)- Summarize the history and frequency of medication errors that occur with insulin use, including highly concentrated insulin U-500Explain how to calculate doses of U-500 insulin in “syringe units” for administration using a U-100 syringe and clearly instruct patients to convert insulin concentrations. Discuss the pharmacokinetic, pharmacodynamic, and clinical properties of concentrated insulin, including U-500 and others in development, and factors for safe administration. Describe the role of pharmacists in counseling patients who are transitioning from inpatient to outpatient settings, to minimize the risk of insulin-administration errors and hospital readmissions.
1.0 Free Contact Hours Safe Use of Concentrated Insulin: Helping Patients and Providers to Get It Right (Part 2)- Calculate doses of U-500 insulin in “syringe units” for administration using a U-100 syringe, and discuss methods for instructing patients to convert insulin concentrations. Incorporate clinical properties of concentrated insulins when developing patient care plans to ensure safe administration. Discuss strategies for counseling patients who are transitioning from inpatient to outpatient settings to minimize the risk of insulin-administration errors.
**Select a course by clicking the title. Courses or fees may have changed on provider’s websites since their posting here. Always check the provider’s website for accreditation information, terms and conditions of courses offered. Courses listed here are not the property of FreeCME4Me, nor do we offer any courses & are not responsible for the those posted on this site
Web Hosting by Hostgator